aTyr Pharma, Inc. (ATYR)

aTyr Pharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	11.06	22.54	9.98	2.34	16.95
Short-Term Investments	61.07	75.62	56.17	105.58	14.74
Cash & Short-Term Investments	72.13	98.17	66.15	107.91	31.69
Cash Growth	-26.53%	48.41%	-38.70%	240.53%	1.75%
Other Receivables	1.74	2.44	11.78	0.44	0.04
Receivables	1.74	2.44	11.78	0.44	0.04
Prepaid Expenses	8.09	2.39	2.95	5.22	1.8
Other Current Assets	-	-	-	-	2
Total Current Assets	81.95	102.99	80.87	113.57	35.53
Property, Plant & Equipment	11.86	14.05	11.56	1.81	2.98
Other Long-Term Assets	3.02	3.62	3.36	0.16	0.21
Total Assets	96.83	120.65	95.79	115.54	38.73
Accounts Payable	4.32	3.53	3.11	1.03	1.43
Accrued Expenses	9.39	11.56	9.86	4	3.57
Current Portion of Leases	1.25	1.33	0.89	0.98	0.86
Total Current Liabilities	14.97	16.42	13.86	6.01	5.86
Long-Term Leases	12.03	13.77	10.64	0.4	1.38
Total Liabilities	27	30.18	24.5	6.41	7.24
Common Stock	0.08	0.06	0.03	0.03	0.01
Additional Paid-In Capital	602.02	558.69	489.5	481.83	370.21
Retained Earnings	-532.05	-468.02	-417.63	-372.3	-338.53
Comprehensive Income & Other	-0.04	-0.07	-0.43	-0.26	-0.04
Total Common Equity	70.02	90.66	71.46	109.3	31.65
Minority Interest	-0.19	-0.19	-0.18	-0.18	-0.17
Shareholders' Equity	69.83	90.47	71.28	109.13	31.48
Total Liabilities & Equity	96.83	120.65	95.79	115.54	38.73
Total Debt	13.28	15.1	11.53	1.38	2.24
Net Cash (Debt)	58.84	83.07	54.61	106.53	29.45
Net Cash Growth	-29.17%	52.11%	-48.74%	261.74%	51.70%
Net Cash Per Share	0.79	1.55	1.92	5.58	3.21
Filing Date Shares Outstanding	88.86	67.75	53.16	27.8	16.01
Total Common Shares Outstanding	84.04	63.29	29.5	27.79	11.02
Working Capital	66.99	86.58	67.01	107.56	29.67
Book Value Per Share	0.83	1.43	2.42	3.93	2.87
Tangible Book Value	70.02	90.66	71.46	109.3	31.65
Tangible Book Value Per Share	0.83	1.43	2.42	3.93	2.87
Machinery	3.74	4.5	5	5	5.82
Leasehold Improvements	5.65	5.65	4.41	1.7	1.7

Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q